Articles tagged with Myocardial Infarction
A recent study found that women are consistently less intensively treated with high-intensity statins after a heart attack, even when prescribed, and across various patient characteristics. This underutilization can lead to preventable vascular events, emphasizing the need for clinicians to communicate the benefits of these medications.
A new study by The George Institute for Global Health found that women in the US are less likely to receive high-intensity statins after a heart attack, despite guidelines recommending them. The study of over 88,000 adults suggests that adherence to these guidelines may be needed to prevent deaths from heart disease and stroke.
Researchers used an experimental therapy to block fibronectin protein, reducing scarred muscle tissue and saving mouse models from heart failure. The treatment restored function in damaged heart cells and reduced fibrosis.
Depression affects cardiovascular disease patients, leading to poorer healthcare experiences, increased healthcare resource use, and higher health costs. Studies found that undiagnosed depression in cardiovascular patients can result in worse healthcare-related quality of life and more emergency room visits.
A study published in the Canadian Journal of Cardiology found a link between Montreal Canadiens victories and an increased risk of heart attacks in men under 55. Winning games produced more heart attacks than losses, with a 40% increase in hospital admissions after home victories.
A randomized controlled trial found that varenicline significantly reduced smoking in patients with heart attack over the following year. The study showed that about 40% of participants who received varenicline were not smoking at one year, compared to 29% in the placebo group.
A large study found that conventional risk factors largely explain the links between loneliness and first-time heart disease/stroke, but social isolation remained an independent risk factor for death among those with pre-existing cardiovascular disease. The study of nearly 480,000 people aged 40-69 found that social isolation was assoc...
A new study published in Annals of Internal Medicine found that hospital quality report cards and readmission penalties may not tell the whole story. The research revealed that when non-Medicare patients and unreported conditions are taken into account, half of hospitals would be subject to a change in their financial penalty status.
Research published in the European Respiratory Journal found that people who have had flu or pneumonia are six times more likely to suffer from a heart attack or stroke in the days following infection. The study highlights the importance of vaccination against these two infections in preventing cardiovascular complications.
A new blood test developed by University of Alberta physician Peter Hwang promises to eliminate the guesswork in diagnosing apparent heart attacks. By analyzing fragmented troponin levels, clinicians can better determine the extent of cardiac damage and make informed decisions about treatment options.
Patients treated with beta blocker metoprolol for 30 days before and after noncardiac surgery were less likely to have heart attacks, but more likely to die or have strokes one year later. The study found that the benefits of beta blockers in reducing heart attacks did not outweigh the increased risk of death or stroke.
A recent study found that six-month dual antiplatelet therapy increases the risk of heart attacks in patients with acute coronary syndrome (ACS). The SMART-DATE trial showed that short-term treatment is not safe for ACS patients who have received drug-eluting stents, highlighting the need for prolonged DAPT in these cases.
Researchers found that imaging technologies more precisely predict who's at risk for heart attacks, allowing for timely prevention. The study used PET/CT imaging to measure coronary artery calcium, revealing existing disease and identifying patients at high risk.
In a trial of over 3,800 patients treated for STEMI at more than 180 centers, researchers found that ticagrelor is safe to use in combination with clot busters in patients younger than 75. The study met its primary endpoint indicating no difference in major bleeding rates between ticagrelor and clopidogrel.
Patients treated with dabigatran had a 28% lower risk of major cardiovascular complications compared to those receiving a placebo. Dabigatran also showed significant benefits in reducing the risk of specific events such as heart attack, stroke and blood clots.
The wearable cardioverter defibrillator was associated with a 35% lower risk of death in patients recovering from a heart attack. While it didn't reduce sudden cardiac deaths, the device showed promise as an interim therapy for patients awaiting evaluation for implantable cardioverter defibrillators.
Patients who receive treatment during periods when interventional cardiologists are away at academic conferences experience a substantial increase in survival rates compared to those treated on matched days. The improvement is primarily driven by a group of patients with a specific type of heart attack that does not require immediate s...
New research suggests that vitamin D may protect heart tissue and reduce the risk of heart failure after a heart attack. The study found that vitamin D prevents excessive scarring and thickening of heart tissue following a heart attack, which can lead to heart failure.
Patients with cardiovascular disease have impaired levels of protective molecules in their blood in the morning, leading to increased risk of blood clots and heart attacks. Replenishing these molecules can improve cell behavior and reduce inflammation.
A recent study published at the American College of Cardiology meeting found a significant link between Inflammatory Bowel Disease (IBD) and an increased risk of heart attacks. The research revealed that IBD is associated with higher odds of having a heart attack, especially in younger patients.
Researchers found that splenic leukocytes play a key role in resolving inflammation after a heart attack, coinciding with cardiac repair. The study highlights the need to investigate macrophage-derived specialized proresolving mediators in heart failure.
Patients with pre-existing health conditions are more likely to die after a heart attack due to the lack of specific guidelines. The study found that clustering of chronic conditions affects mortality rates, with those in high multimorbidity groups having poorer outcomes.
A study found that large day-to-day swings in outdoor temperature are associated with a significantly increased risk of heart attacks. The researchers calculated the temperature fluctuation preceding each heart attack and found that a five-degree jump in temperature differential was linked to a 5% increase in heart attack rates.
A study analyzing medical records from over 17.5 million patients found that people with inflammatory bowel disease are at elevated risk for a heart attack, regardless of traditional risk factors. Younger patients, especially those under 40 years old and females, face the highest risks.
A study found that aspirin reduces mortality in patients with Type 2 diabetes and heart failure, but increases the risk of nonfatal heart attacks and strokes. The research used data from over 12,000 patients and suggested that aspirin may be beneficial for those living longer due to their age.
The American College of Cardiology's Patient Navigator Program has shown significant improvement in transitioning heart attack and heart failure patients from hospital to home, reducing readmissions and in-hospital mortality. Hospitals participating in the program have increased prescriptions of life-saving medications, scheduled follo...
A new scientific statement by a Mayo Clinic led team suggests that conservative treatment may be more effective for women with SCAD. The average age of women with SCAD ranges from 45 to 53 years, and it is the No. 1 cause of heart attack during pregnancy and in the period right after giving birth.
A new smartphone app called 'Corrie' has been designed to help patients navigate the hospital discharge process and transition to home after a heart attack. The app allows patients to track medications, follow-up appointments, and lifestyle changes, resulting in a lower readmission rate compared to standard care.
A new study published in Circulation found that 8% of women with chest pain have myocardial scar, indicating previous heart muscle damage. The study suggests that women be taken seriously when complaining of chest pain and receive appropriate medical care.
Research found that resolvin D-1 limits heart attack-induced kidney inflammation and promotes reparative macrophage change. This suggests potential application to clinical settings for treating cardiorenal syndrome.
Researchers found a significant association between rapid increases in air pollution and cardiovascular risk, even in clean air cities. Nitric oxide increases of over 20 μg/m3 within 24 hours doubled the risk of heart attack.
A quality improvement toolkit improved the quality of care but not outcomes in hospitals in Kerala, India. The study found favorable trends in outcomes among heart attack patients, with lower rates of major cardiovascular events at discharge compared to usual care.
A new study from the University of Sheffield has found that patients with a longer clot lysis time are at higher risk of recurrent myocardial infarction or death due to cardiovascular disease. The research may lead to new treatments targeting fibrin clot lysis time, aiming to reduce this risk.
A new interaction between proteins could provide a breakthrough in the prevention of healthy blood vessel damage. The study found that stabilizing caveolae regions prevents damage by binding protein SOCS3 with Cavin-1, maintaining healthy vascular function.
Research suggests that migraine is associated with an increased risk of cardiovascular diseases in both men and women. The study found a positive association between migraine and heart attack, stroke, blood clots, and irregular heart rate, particularly among women.
Researchers at Ohio University found that Vitamin D3 can restore damaged cardiovascular systems and reduce the risk of heart attack. The study used nanosensors to track the impacts of Vitamin D3 on single endothelial cells, revealing its powerful stimulatory effects on nitric oxide and reduction in oxidative stress.
A new high-sensitivity troponin (hsTn) assay can measure lower concentrations of troponin, allowing for earlier diagnosis of heart attacks. The test has shown a significant reduction in wait times for emergency department patients, as well as improved patient satisfaction and safety.
Researchers created human cardiac-muscle patches that significantly improved recovery from heart attack injury in large animals. The patches also reduced infarct size, wall stress, and apoptosis, while preventing arrhythmia.
Researchers have identified lymphocyte clusters in the pericardial adipose tissue as key regulators of the post-infarction immune response. These clusters stimulate an immune reaction that degrades damaged tissues, but also promote tissue repair. The findings suggest a critical role for this process in heart healing.
Researchers developed a predictive tool to accurately estimate cardiac risks for older patients undergoing non-cardiac surgery. The 'Geriatric-Sensitive Perioperative Cardiac Risk Index' considers age-specific risk factors and significantly outperforms traditional tools.
A comprehensive study of heart-spleen and heart-kidney networks reveals the interconnectedness of organ damage after a heart attack. Researchers found histological and cellular changes in the spleen and kidney, as well as bimodal inflammatory responses and irreversible dysregulation in the cardiosplenic and cardiorenal networks.
A Canadian-led study found that perioperative aspirin can prevent heart-related complications after major noncardiac surgery in patients with previous percutaneous coronary intervention (PCI). For every 1,000 patients with PCI, giving them aspirin at the time of noncardiac surgery would prevent 59 heart attacks and cause eight major bl...
Researchers found that CT scans and cardiac stress tests provide no information to determine whether a patient is having a heart attack, leading to unnecessary costs and extended hospital stays. The study suggests over-testing and over-treating patients with chest pain in the ER.
Researchers found that individuals with A, B, and AB blood types have an elevated risk of heart attacks during times of significant air pollution compared to those with O blood type. The study links increased risk of heart attack associated with small particulate pollution to increased risk for people with coronary artery disease.
A registry-based study from Aarhus University found that heart attack survivors are at a higher risk of developing vascular dementia, which is caused by vascular damage in the brain. The risk remains elevated for up to 35 years after the heart attack, with patients who underwent bypass surgery showing a fourfold increased risk.
Evolocumab reduced risk of major cardiovascular events and major adverse limb events among patients with peripheral artery disease. The PCSK9 inhibitor also lowered the number needed to treat to prevent adverse events, making it a promising treatment option for this high-risk population.
Research found that 15% of heart attack and stroke patients, and 9% of CABG patients, were uninsured during 2008-2012. Hospital bills exceeded 40% of annual income for 85% of heart attack patients, 75% of stroke patients, and 83% of CABG patients.
A low-cost rapid blood test can accurately rule out heart attack risk in nearly half of all patients with chest pain, saving millions from further tests and reducing healthcare costs. The test, which measures troponin levels in the blood, can identify a threshold level below which patients are unlikely to have had a heart attack.
Researchers found that statins prescribed at the time of discharge significantly reduce the risk of future heart attacks, strokes, or other cardiovascular events. High-intensity statin doses showed greater benefits, particularly for younger patients, with a 21% reduction in risk.
A study of over 60,000 patients with known heart disease found that follow-up LDL cholesterol tests significantly reduce the risk of reoccurring heart attacks and strokes. Patients who didn't receive these tests were more likely to experience major adverse outcomes.
A study of over 100,000 patients found that low blood phosphate levels were associated with a similar risk of coronary problems as elevated levels. This contradicts previous research suggesting low volumes of the mineral were beneficial to cardiovascular health.
Researchers found that dying cell DNA stimulates an ancient antiviral program in immune cells, leading to inflammation and heart dysfunction. Blocking this response improves survival rates in mice, suggesting a new potential therapeutic opportunity for preventing heart failure.
The SENIOR trial found that a Synergy bioabsorbable polymer DES with shorter dual antiplatelet therapy (DAPT) is more effective than a bare-metal stent in elderly patients. This new strategy reduces adverse events without increasing bleeding risk, suggesting a change in recommended PCI strategies for this age group.
The DAPT STEMI trial found that six months of dual antiplatelet therapy was non-inferior to twelve months in STEMI patients receiving drug-eluting stents, questioning the need for extended duration DAPT. The study's results suggest that STEMI patients may not benefit from prolonged DAPT therapy beyond six months.
A study of 2500 elderly patients found that delays in getting to the hospital are common among non-white individuals and those experiencing atypical symptoms. These delays can have life-threatening consequences, emphasizing the need for improved clinical and public health strategies to ensure timely presentation.
Researchers at UAB discovered that overexpressing a cell-cycle activator gene CCND2 increases the proliferation of grafted cardiomyocytes, leading to improved cardiac function and reduced infarct size. This breakthrough may pave the way for future clinical treatment of human heart attack patients.
A study published in JAMA Internal Medicine found that women with a history of gestational diabetes were at a modestly higher risk of cardiovascular disease. However, adhering to a healthy lifestyle appeared to help mitigate this risk in younger women, particularly those who were predominantly white and followed healthy habits over time.
A Danish study found that one in four people leave their job within a year of returning to work after having a heart attack. The study analyzed long-term employment patterns and found that younger people, those with heart failure or depression, were more likely to drop out of the workforce.
A new cardiac catheter combines fluorescence lifetime imaging (FLIm) with intravascular ultrasound to measure plaque composition, providing a more accurate prediction of heart attacks. The device has been tested in living swine hearts and human coronary artery samples, showing promising results.
Researchers found that stopping long-term low-dose aspirin therapy increases the risk of cardiovascular events by 37%. Stopping aspirin use can lead to a 'rebound effect', with increased clotting levels causing an elevated risk of cardiovascular events that does not diminish over time.